Does TRAVOPROST Cause Product packaging quantity issue? 66 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Product packaging quantity issue have been filed in association with TRAVOPROST (Travoprost Ophthalmic Soluton). This represents 1.0% of all adverse event reports for TRAVOPROST.
66
Reports of Product packaging quantity issue with TRAVOPROST
1.0%
of all TRAVOPROST reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product packaging quantity issue From TRAVOPROST?
Of the 66 reports, 1 (1.5%) required hospitalization.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRAVOPROST. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does TRAVOPROST Cause?
Treatment failure (2,364)
Ocular hyperaemia (478)
Drug ineffective (467)
Eye irritation (448)
Intraocular pressure increased (335)
Hypersensitivity (305)
Glaucoma (286)
Eye pain (284)
Visual impairment (264)
Vision blurred (180)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which TRAVOPROST Alternatives Have Lower Product packaging quantity issue Risk?
TRAVOPROST vs TRAZODONE
TRAVOPROST vs TREANDA
TRAVOPROST vs TREMELIMUMAB
TRAVOPROST vs TREMELIMUMAB\TREMELIMUMAB-ACTL
TRAVOPROST vs TRENBOLONE